Skip to main content

Clarification: Mar 3, 2005


The most recent issue of Pharmacogenomics Reporter omitted the journals in which secondary Tarceva- and Iressa-resistance research papers were published. The research group from Beth Israel Deaconess Medical Center published in the Feb. 24 issue of The New England Journal of Medicine, while the group from the Memorial Sloan-Kettering Cancer Center published in the Feb. 22 issue of PLoS Medicine.

Filed under

The Scan

Pfizer-BioNTech Seek Full Vaccine Approval

According to the New York Times, Pfizer and BioNTech are seeking full US Food and Drug Administration approval for their SARS-CoV-2 vaccine.

Viral Integration Study Critiqued

Science writes that a paper reporting that SARS-CoV-2 can occasionally integrate into the host genome is drawing criticism.

Giraffe Species Debate

The Scientist reports that a new analysis aiming to end the discussion of how many giraffe species there are has only continued it.

Science Papers Examine Factors Shaping SARS-CoV-2 Spread, Give Insight Into Bacterial Evolution

In Science this week: genomic analysis points to role of human behavior in SARS-CoV-2 spread, and more.